Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function

28 Feb 2024

Abstract excerpt

Background Disturbed gut microbiota and associated metabolic dysfunction exist in Psoriasis. Despite the growing use of interleukin-17 inhibitor (anti-IL17) therapy, the effect of anti-IL17 on gut/skin microbiota function is not fully understood in patients with Psoriasis. Objective Therefore, we explored whether Psoriasis is associated with alterations in selected gut/skin microbiota in a study cohort, and a...

Topics

Join the communities discussing this publication.

Dermatology and Skin Diseases
Gut microbiota and health
Psoriasis: Treatment and Pathogenesis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38482003
DOI: 10.3389/fimmu.2024.1344963

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota functionPMID 38482003Read ↗

Role of skin and gut microbiota in the pathogenesis of psoriasis, an inflammatory skin diseaseSemantic proximity Read ↗

Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarizationSemantic proximity Read ↗

Gut microbiota dysbiosis in a cohort of patients with psoriasisSemantic proximity Read ↗

Gut Microbiome in Psoriasis: An Updated ReviewSemantic proximity Read ↗

Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patientsSemantic proximity Read ↗

Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome IndexSemantic proximity Read ↗

Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patientsSemantic proximity Read ↗

Deciphering Gut Microbiota Dysbiosis and Corresponding Genetic and Metabolic Dysregulation in Psoriasis Patients Using Metagenomics SequencingSemantic proximity Read ↗

Metagenomic Analysis of the Gut Microbiome in Psoriasis Reveals Three Subgroups with Distinct Host-Microbe InteractionsSemantic proximity Read ↗

Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic ArthritisSemantic proximity Read ↗

Psoriasis: Embarking a dynamic shift in the skin microbiotaSemantic proximity Read ↗

Involvement of Gut Microbiota in the Development of Psoriasis VulgarisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.